Key Insights
- CMS introduced significant revisions to destruction and biopsy code families effective January 1, 2026.
- New biopsy code descriptors require documentation of technique specificity — tangential, punch, or incisional.
- Mohs staging codes saw documentation requirement updates affecting operative notes and pathology report standards.
- Practices using 2025 superbills or EHR templates are at high risk of systematic claim rejections.
- Early adopters of updated protocols are seeing 12–18% improvement in clean claim rates through Q1 2026.
The Scale of 2026 Code Changes
Each year, the American Medical Association releases CPT code updates that require dermatology practices to revise their superbills, EHR charge capture templates, and billing team training. In 2026, the volume and significance of dermatology-specific changes is above average — making January 1 implementation deadlines more consequential than usual.
Practices that fail to implement these changes risk submitting claims with deleted, revised, or incorrectly described codes. In most cases, this results in automatic rejection rather than denial — meaning the claim does not even enter adjudication and the practice may not receive a remittance notification. Revenue simply disappears.
Key Changes by Code Family
Biopsy Codes (11102–11107)
The 2026 updates clarify and tighten the documentation requirements for the biopsy code family that was restructured in 2019. The new descriptor language explicitly requires that the technique used — tangential shave, punch, or incisional — be identified in the procedure note, not just the pathology requisition.
This matters because many practices document biopsy technique in the pathology order form (which is not part of the medical record for billing purposes) rather than the clinical note. Starting January 1, 2026, payers auditing these codes will be looking for technique documentation in the procedure note itself.
If your procedure note template says "biopsy performed" without specifying technique, update it immediately. Every biopsy claim is now at documentation risk without this specificity.
Destruction Codes (17000–17286)
The destruction code family saw two significant changes. First, the definition of "lesion" for counting purposes has been clarified — adjacent lesions treated in a single pass are no longer separately countable unless they represent distinct anatomic sites with separate documentation.
Second, the medical necessity documentation requirements for destruction of benign lesions have been strengthened. Payers now expect clinical justification for benign lesion destruction — symptomatic documentation (bleeding, irritation, functional impairment) rather than cosmetic concern — or the claim will be denied as not medically necessary.
Mohs Surgery Codes (17311–17315)
Mohs codes in 2026 have two notable updates. The pathology report standard has been aligned with current College of American Pathologists (CAP) guidelines — specifically requiring that the report explicitly document the tissue orientation, number of sections examined, and confirmation that all margins are clear before reconstruction codes can be billed on the same date.
The second update affects billing of the first stage versus subsequent stages. The 2026 CPT descriptor now explicitly requires that the physician performing the surgery also personally perform or directly supervise the tissue processing and histologic examination for each stage — clarifying a longstanding ambiguity about pathologist involvement.
Implementation Checklist for Your Practice
Audit Your Superbill
Pull your current superbill and cross-reference every dermatology CPT code against the 2026 AMA CPT codebook. Flag deleted, revised, or new codes.
Update EHR Templates
Revise procedure note templates to capture required documentation elements — particularly biopsy technique specification and destruction medical necessity language.
Retrain Billing Team
Conduct a 90-minute coding update session with your billing staff covering the most impactful changes. Provide a reference sheet for the 10 most commonly used codes.
Run First-Week Audit
Pull and review the first 50 claims submitted in January 2026. Check for correct code selection and documentation compliance. Catch systematic errors early.
The Payer Lag Problem
A critical operational nuance: most commercial payers do not update their fee schedules and edit logic on January 1. Many take 60–90 days to fully implement CPT changes — meaning claims submitted with new codes in January may be rejected by payers still running 2025 editing logic.
This creates a short-term operational challenge: practices must be prepared to submit claims correctly per 2026 CPT standards while simultaneously managing rejections from payers that haven't caught up. The appropriate response is to resubmit with the correct 2026 code and document the submission timeline to avoid timely filing issues.
Working with a billing partner who monitors payer-specific update timelines eliminates this administrative burden and ensures claims are routed to the correct submission protocol for each payer during the transition period.
Key Takeaways
- Update your superbill before January 1 — using deleted or revised codes results in automatic rejection, not denial.
- Biopsy procedure notes must now specify technique (tangential, punch, or incisional) — update your EHR templates immediately.
- Destruction of benign lesions requires documented medical necessity justification — cosmetic intent is not a covered indication.
- Mohs pathology reports must align with 2026 CAP standards before reconstruction codes can be billed on the same date.
- Run a 50-claim audit in the first week of January to catch systematic template or code selection errors early.
- Commercial payers may take 60–90 days to implement CPT changes — have a rejection management protocol for the transition period.
Ready to Stop Leaving Revenue on the Table?
Schedule a free revenue cycle assessment with our dermatology billing specialists. We'll identify your specific revenue leaks and show you a clear path to recovery.